Income/(Loss) per Common Share

The computation of basic net income/(loss) per share is based on the weighted average number of common shares outstanding for the years ended December 31, 2018, 2017 and 2016. As of December 31, 2018 and 2017, the Company had 3,040,540 outstanding warrants convertible to 152,027 shares of the Company's common stock with an exercise price of $556.40 per share. The warrants have a 7 year term and will expire on October 15, 2021. Diluted net income/(loss) per share gives effect to stock awards, stock options and restricted stock units using the treasury stock method, unless the impact is anti-dilutive.

Diluted net income per share for the year ended December 31, 2018 does not include 687 unvested stock awards, 348,625 stock options and outstanding warrants convertible to 152,027 shares of common stock as their effect was anti-dilutive.

Diluted net loss per share for the year ended December 31, 2017 does not include 1,716,928 unvested stock awards, 2,301,046 stock options and outstanding warrants convertible to 152,027 shares of common stock as their effect was anti-dilutive.

Diluted net loss per share for the year ended December 31, 2016 does not include 1,413,461 unvested stock awards, 1,942,909 stock options and outstanding warrants convertible into 152,027 shares of common stock as their effect was anti-dilutive.



	For the Years Ended
	December 31, 2018		December 31, 2017			December 31, 2016
Net income/(loss)	$	12,574,684	$	(43,796,685	)	$	(223,522,435	)
Weighted Average Shares-Basic	70,665,212		69,182,302			20,565,652
Dilutive effect of stock options, warrants and restricted stock units	1,136,961		—			—
Weighted Average Shares - Diluted	71,802,173		69,182,302			20,565,652
Basic income/(loss) per share	$	0.18	$	(0.63	)	$	(10.87	)
Diluted income/(loss) per share	$	0.18	$	(0.63	)	$	(10.87	)